Brief: Immucell Reports Total Product Sales Rose 25% To $3.7 Mln During 3-Month Period Ended Sept. 30
Oct 6 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES PRELIMINARY, UNAUDITED SALES RESULTS
FOR THE
QUARTER ENDED SEPTEMBER 30, 2020
* IMMUCELL CORP - TOTAL PRODUCT SALES ROSE 25% TO $3.7
MILLION
DURING 3-MONTH PERIOD ENDED SEPT. 30
Source text for Eikon: ID:nGNX3n93l2
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year